127 related articles for article (PubMed ID: 11948876)
1. A fast and efficient metal-mediated oxidation of isoniazid and identification of isoniazid-NAD(H) adducts.
Nguyen M; Claparols C; Bernadou J; Meunier B
Chembiochem; 2001 Dec; 2(12):877-83. PubMed ID: 11948876
[TBL] [Abstract][Full Text] [Related]
2. Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis.
Nguyen M; Quémard A; Broussy S; Bernadou J; Meunier B
Antimicrob Agents Chemother; 2002 Jul; 46(7):2137-44. PubMed ID: 12069966
[TBL] [Abstract][Full Text] [Related]
3. 1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
Broussy S; Coppel Y; Nguyen M; Bernadou J; Meunier B
Chemistry; 2003 May; 9(9):2034-8. PubMed ID: 12740851
[TBL] [Abstract][Full Text] [Related]
4. [The mechanism of action of isoniazid. A chemical model of activation].
Bernadou J; Nguyen M; Meunier B
Ann Pharm Fr; 2001 Sep; 59(5):331-7. PubMed ID: 11787427
[TBL] [Abstract][Full Text] [Related]
5. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
[TBL] [Abstract][Full Text] [Related]
6. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.
Rawat R; Whitty A; Tonge PJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13881-6. PubMed ID: 14623976
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD
Babu D; Morgan AG; Reiz B; Whittal RM; Almas S; Lacy P; Siraki AG
Chem Biol Interact; 2019 May; 305():48-53. PubMed ID: 30922765
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites.
Khan SR; Morgan AG; Michail K; Srivastava N; Whittal RM; Aljuhani N; Siraki AG
Biochem Pharmacol; 2016 Apr; 106():46-55. PubMed ID: 26867495
[TBL] [Abstract][Full Text] [Related]
10. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
[TBL] [Abstract][Full Text] [Related]
11. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
[TBL] [Abstract][Full Text] [Related]
12. 1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
Broussy S; Bernardes-Génisson V; Coppel Y; Quémard A; Bernadou J; Meunier B
Org Biomol Chem; 2005 Feb; 3(4):670-3. PubMed ID: 15703806
[TBL] [Abstract][Full Text] [Related]
13. A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct.
Mahapatra S; Woolhiser LK; Lenaerts AJ; Johnson JL; Eisenach KD; Joloba ML; Boom WH; Belisle JT
Antimicrob Agents Chemother; 2012 Jan; 56(1):28-35. PubMed ID: 22037847
[TBL] [Abstract][Full Text] [Related]
14. Catalase-peroxidases (KatG) exhibit NADH oxidase activity.
Singh R; Wiseman B; Deemagarn T; Donald LJ; Duckworth HW; Carpena X; Fita I; Loewen PC
J Biol Chem; 2004 Oct; 279(41):43098-106. PubMed ID: 15280362
[TBL] [Abstract][Full Text] [Related]
15. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents.
Delaine T; Bernardes-Génisson V; Quémard A; Constant P; Meunier B; Bernadou J
Eur J Med Chem; 2010 Oct; 45(10):4554-61. PubMed ID: 20696503
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis.
Lu XY; You QD; Chen YD
Mini Rev Med Chem; 2010 Mar; 10(3):181-92. PubMed ID: 20408801
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.
Laborde J; Deraeve C; de Mesquita Vieira FG; Sournia-Saquet A; Rechignat L; Villela AD; Abbadi BL; Macchi FS; Pissinate K; Bizarro CV; Machado P; Basso LA; Pratviel G; de França Lopes LG; Sousa EHS; Bernardes-Génisson V
J Inorg Biochem; 2018 Feb; 179():71-81. PubMed ID: 29175704
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.
Inturi B; Pujar GV; Purohit MN
Arch Pharm (Weinheim); 2016 Nov; 349(11):817-826. PubMed ID: 27775177
[TBL] [Abstract][Full Text] [Related]
19. The first chemical synthesis of the core structure of the benzoylhydrazine-NAD adduct, a competitive inhibitor of the Mycobacterium tuberculosis enoyl reductase.
Broussy S; Bernardes-Génisson V; Quémard A; Meunier B; Bernadou J
J Org Chem; 2005 Dec; 70(25):10502-10. PubMed ID: 16323864
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.
da Costa AL; Pauli I; Dorn M; Schroeder EK; Zhan CG; de Souza ON
J Mol Model; 2012 May; 18(5):1779-90. PubMed ID: 21833828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]